Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 1,454 | 12,494 | 3,976 | 3,890 | 8,760 |
| Cost of Goods | N/A | N/A | N/A | N/A | 1,142 |
| Gross Profit | 1,454 | 12,494 | 3,976 | 3,890 | 7,618 |
| Operating Expenses | 29,947 | 30,745 | 26,190 | 21,751 | 21,109 |
| Operating Income | -28,493 | -18,251 | -22,214 | -17,861 | -13,349 |
| Interest Expense | 2,346 | 2,195 | 2,221 | 2,231 | 2,140 |
| Other Income | 1,242 | 2,000 | -1,342 | 549 | 355 |
| Pre-tax Income | -29,597 | -18,446 | -25,777 | -19,543 | -15,134 |
| Net Income Continuous | -29,597 | -18,446 | -25,777 | -19,543 | -15,134 |
| Net Income | $-29,597 | $-18,446 | $-25,777 | $-19,543 | $-15,134 |
| EPS Basic Total Ops | -0.28 | -0.19 | -0.26 | -0.20 | -0.18 |
| EPS Basic Continuous Ops | -0.28 | -0.19 | -0.26 | -0.20 | -0.18 |
| EPS Diluted Total Ops | -0.28 | -0.19 | -0.26 | -0.20 | -0.18 |
| EPS Diluted Continuous Ops | -0.28 | -0.19 | -0.26 | -0.20 | -0.18 |
| EBITDA(a) | $-28,065 | $-17,773 | $-21,720 | $-17,429 | $-12,913 |